Co-Diagnostics, Inc. (CODX)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $0.44
- As of
Kresmion compiles this page from CODX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Co-Diagnostics, Inc. (CODX): 2 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-15.
See the full CODX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CODX on one page. Preview it with sample data, then open it live with a free account.
Preview the CODX dossierActive events for CODX
- mediumEarnings above estimates
Q2-2026: Beat consensus by 52.3%, EPS $-1.46 vs $-3.06 estimate
- medium13F: new position
MILLENNIUM MANAGEMENT LLC new position in CODX
- medium13F: new position
RENAISSANCE TECHNOLOGIES LLC new position in CODX
- mediumEarnings above estimates
Q2-2025: Beat consensus by 63.6% - EPS $-6.9 vs $-18.972 estimate
- mediumEarnings below estimates
Q1-2026: Missed consensus by 6.1% - EPS $-4.06 vs $-3.825 estimate
FREE, NO ACCOUNT
Every event on CODX, as it fires
You are seeing 5 of 7 events recorded on CODX since 2026-05-29.
The five above landed across 3 days. The other 2 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in CODX (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 189763204 · 2026Q2 | $99K | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 189763204 · 2026Q2 | $39K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, CODX
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
CODX against its peers
CODX's operating margin of -8058.8% ranks in the 11th percentile of 13 Medical Devices sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.
| Metric | CODX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 622489 USD | 3.4M USD | 21 | 16 |
| Gross margin | 64.3% | 44.6% | 81 | 12 |
| Operating margin | -8058.8% | -162.9% | 11 | 13 |
| Net margin | -7533.6% | -253.4% | 10 | 14 |
| Return on equity | -227.3% | -213.9% | 43 | 14 |
Peers (19): VVOS, STME, ICCM, USAQ, INBS, AIDX, WOK, AMIX, NVNO, ADGM, RMSL, VNRX, TNON, IVF, BJDX, ADMT, NUWE, VYCO, XAIR. Left out: PMEDF (period gap), KLYG (no annual filing), TRIB (period gap), SONX (period gap), CYDX (no annual filing), FZMD (period gap). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (CODX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow CODX on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to CODX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.